| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $310.2M | — | +1.5% |
| Gross Profit | $259.2M | — | +0.3% |
| R&D Expense | $42.1M | — | -17.6% |
| SG&A Expense | $50.8M | — | +10.9% |
| Operating Income | $57.9M | — | +15.1% |
| Pre-tax Income | $44.3M | — | +11.9% |
| Income Tax | $15.0M | — | +17.2% |
| Net Income | $29.3M | — | +9.3% |
| EPS (Basic) | $0.10 | — | +25.0% |
| EPS (Diluted) | $0.10 | — | +25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $171.2M | -2.7% | +23.6% |
| Short-term Investments | $4.0M | +0.0% | +100.0% |
| Accounts Receivable | $183.8M | -18.5% | -9.8% |
| Current Assets | $410.0M | -9.7% | -0.0% |
| Total Assets | $6.37B | -1.1% | -0.6% |
| Current Liabilities | $598.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $114.7M | — | -3.8% |
| Investing Cash Flow | -$26.0M | — | -38.3% |
| Financing Cash Flow | -$93.2M | — | +8.5% |
| -4.1% |
| Long-term Debt | $1.32B | -0.1% | +7.8% |
| Total Liabilities | $4.90B | -0.7% | +2.9% |
| Stockholders' Equity | $1.47B | -2.3% | -10.5% |